Page 22 Acute Pain Management
P. 22




14.
 The
incidence
of
clinically
meaningful
adverse
effects
of
opioids
is
dose‐related
(U)

(Level
II).


15.
 High
doses
of
methadone
can
lead
to
prolonged
QT
interval
(N)
(Level
II).

16.
 Haloperidol
is
effective
in
the
prevention
of
postoperative
nausea
and
vomiting
(N)

(Level
II).

17.
 Opioid
antagonists
are
effective
treatments
for
opioid‐induced
urinary
retention
(N)

(Level
II).

18.
 In
clinically
relevant
doses,
there
is
a
ceiling
effect
for
respiratory
depression
with

SUMMARY
 19.
 Assessment
of
sedation
is
a
more
reliable
way
of
detecting
early
opioid‐induced

buprenorphine
but
not
for
analgesia
(N)
(Level
III‐2).


respiratory
depression
than
a
decreased
respiratory
rate
(S)
(Level
III‐3).

20.
 The
evidence
for
risk
of
cardiac
arrhythmias
following
low‐dose
droperidol
is
poor
(N)

(Level
III‐3).

21.
 In
adults,
patient
age
rather
than
weight
is
a
better
predictor
of
opioid
requirements,

although
there
is
a
large
interpatient
variation
(U)
(Level
IV).


22.
 Impaired
renal
function
and
the
oral
route
of
administration
result
in
higher
levels
of
the

morphine
metabolites
morphine‐3‐glucuronide
and
morphine‐6‐glucuronide
with

increased
risk
of
sedation
and
respiratory
depression
(S)
(Level
IV).


 The
use
of
pethidine
(U)
and
dextropropoxyphene
(N)
should
be
discouraged
in
favour
of

other
opioids.


Paracetamol,
non‐selective
non‐steroidal
anti‐inflammatory
drugs
and
coxibs

1.
 Paracetamol
is
an
effective
analgesic
for
acute
pain;
the
incidence
of
adverse
effects

comparable
to
placebo
(S)
(Level
I
[Cochrane
Review]).

2.
 Non‐selective
NSAIDs
are
effective
in
the
treatment
of
acute
postoperative
and
low
back

pain,
renal
colic
and
primary
dysmenorrhoea
(N)
(Level
I
[Cochrane
Review]).


3.
 Coxibs
are
effective
in
the
treatment
of
acute
postoperative
pain
(N)
(Level
I
[Cochrane

Review]).

4.
 With
careful
patient
selection
and
monitoring,
the
incidence
of
nsNSAID‐induced

perioperative
renal
impairment
is
low
(U)
(Level
I
[Cochrane
Review]).


5.
 Non‐selective
NSAIDs
do
not
increase
the
risk
of
reoperation
for
bleeding
after

tonsillectomy
in
paediatric
patients
(Q)
(Level
I
[Cochrane
Review]).


6.
 Coxibs
do
not
appear
to
produce
bronchospasm
in
individuals
known
to
have
aspirin‐
exacerbated
respiratory
disease
(U)
(Level
I).

7.
 In
general,
aspirin
increases
bleeding
after
tonsillectomy
(N)
(Level
I).

8.
 Non‐selective
NSAIDs
given
in
addition
to
paracetamol
improve
analgesia
compared
with

paracetamol
alone
(U)
(Level
I).

9.
 Paracetamol
given
in
addition
to
PCA
opioids
reduces
opioid
consumption
but
does
not

result
in
a
decrease
in
opioid‐related
side
effects
(N)
(Level
I).

10.
 Non‐selective
NSAIDs
given
in
addition
to
PCA
opioids
reduce
opioid
consumption
and

the
incidence
of
nausea,
vomiting
and
sedation
(N)
(Level
I).




xxii
 Acute
Pain
Management:
Scientific
Evidence

   17   18   19   20   21   22   23   24   25   26   27